0R15 8884.0068 1.4156% 0R1E 9171.0 0.0% 0M69 None None% 0R2V 255.5 0.0% 0QYR 1619.0 0.0% 0QYP 434.5 0.0% 0RUK None None% 0RYA 1606.0 4.9673% 0RIH 195.2 1.3763% 0RIH 195.2 0.0% 0R1O 225.5 9900.0% 0R1O None None% 0QFP None None% 0M2Z 255.0 0.2457% 0VSO 33.3 -6.4738% 0R1I None None% 0QZI 604.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 246.8 2.9706%
Last update at 2024-12-26T18:51:00Z
Winners And Losers Of Q2: Amplitude (NASDAQ:AMPL) Vs The Rest Of The Data Analytics Stocks
Mon 14 Oct 24, 08:56 AMWinners And Losers Of Q2: Domo (NASDAQ:DOMO) Vs The Rest Of The Data Analytics Stocks
Fri 11 Oct 24, 07:05 AMQ2 Data Analytics Earnings: Palantir (NYSE:PLTR) Impresses
Wed 02 Oct 24, 09:36 AMData Analytics Stocks Q2 Recap: Benchmarking Samsara (NYSE:IOT)
Tue 01 Oct 24, 09:56 AMData Analytics Stocks Q1 Earnings: Samsara (NYSE:IOT) Best of the Bunch
Fri 02 Aug 24, 09:41 AM3 Overlooked Telehealth Stocks Poised for a Comeback
Tue 16 Jul 24, 12:00 AM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -141.68300M | -160.10800M | -116.21100M | -59.95400M | -62.11900M |
| Minority interest | - | - | - | - | 0.00000M |
| Net income | -137.40300M | -153.21000M | -115.01700M | -60.09600M | -61.98400M |
| Selling general administrative | 61.70M | 85.93M | 59.24M | 31.71M | 22.69M |
| Selling and marketing expenses | 87.51M | 75.03M | 55.41M | 47.28M | 44.12M |
| Gross profit | 133.19M | 117.57M | 90.77M | 79.60M | 52.72M |
| Reconciled depreciation | 48.30M | 37.53M | 18.73M | 9.21M | 7.41M |
| Ebit | -140.00500M | -143.65000M | -96.12500M | -54.86500M | -59.53200M |
| Ebitda | -91.70800M | -106.12200M | -77.40000M | -45.65300M | -52.12000M |
| Depreciation and amortization | 48.30M | 37.53M | 18.73M | 9.21M | 7.41M |
| Non operating income net other | - | - | -8.51400M | - | 0.00000M |
| Operating income | -140.00500M | -143.65000M | -96.12500M | -54.86500M | -60.09500M |
| Other operating expenses | 416.24M | 385.58M | 284.97M | 209.81M | 172.67M |
| Interest expense | 1.68M | 16.46M | 11.57M | 3.42M | 2.59M |
| Tax provision | -4.28000M | -6.89800M | -1.19400M | 0.14M | -0.13500M |
| Interest income | 5.69M | 0.83M | 2.09M | 2.81M | 0.60M |
| Net interest income | -1.55200M | -16.48200M | -11.62200M | -3.45100M | -1.98500M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.00000M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | -4.28000M | -6.89800M | -1.19400M | 0.14M | -0.13500M |
| Total revenue | 276.24M | 241.93M | 188.84M | 154.94M | 112.57M |
| Total operating expenses | 273.19M | 261.22M | 186.89M | 134.46M | 112.82M |
| Cost of revenue | 143.05M | 124.35M | 98.08M | 75.34M | 59.85M |
| Total other income expense net | -1.67800M | -16.45800M | -20.08600M | -5.08900M | -0.03900M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | -137.40300M | -153.21000M | -115.01700M | -60.09600M | -61.98400M |
| Net income applicable to common shares | -137.40300M | -153.21000M | -115.01700M | -240.92200M | -114.02100M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 701.81M | 752.29M | 832.10M | 577.74M | 302.36M |
| Intangible assets | 73.38M | 92.19M | 104.79M | 98.92M | 25.54M |
| Earning assets | - | - | - | - | - |
| Other current assets | 12.28M | 16.34M | 14.61M | 10.63M | 8.39M |
| Total liab | 334.89M | 327.28M | 310.00M | 301.64M | 101.72M |
| Total stockholder equity | 366.92M | 425.01M | 522.10M | 276.10M | 200.64M |
| Deferred long term liab | - | 2.60M | 3.00M | 1.40M | - |
| Other current liab | 23.28M | 19.69M | 28.30M | 32.94M | 11.14M |
| Common stock | 1484.06M | 1424.68M | 0.05M | 0.04M | 0.04M |
| Capital stock | 1484.06M | 1424.68M | 0.05M | 0.04M | 0.04M |
| Retained earnings | -1117.17000M | -999.02300M | -878.86000M | -725.65000M | -610.51400M |
| Other liab | - | 0.23M | 15.76M | 20.94M | 3.65M |
| Good will | 190.65M | 185.98M | 169.97M | 107.82M | 3.69M |
| Other assets | 0.00000M | 3.73M | 4.50M | 28.34M | 0.81M |
| Cash | 106.28M | 116.31M | 193.23M | 91.95M | 18.03M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 89.03M | 82.51M | 93.05M | 88.04M | 48.22M |
| Current deferred revenue | 55.75M | 54.96M | 56.63M | 47.15M | 30.65M |
| Net debt | 142.79M | 131.66M | 11.38M | 103.33M | 34.63M |
| Short term debt | 3.36M | 3.43M | 3.42M | 2.62M | 2.81M |
| Short long term debt | - | - | - | - | - |
| Short long term debt total | 249.07M | 247.97M | 204.61M | 195.28M | 52.66M |
| Other stockholder equity | - | -0.64800M | 1400.97M | 1001.64M | 508.69M |
| Property plant equipment | - | 42.59M | 44.45M | 12.86M | 8.08M |
| Total current assets | 391.20M | 427.80M | 508.39M | 329.80M | 264.24M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | 146.84M | 247.34M | 69.36M | 171.41M |
| Short term investments | 211.45M | 247.18M | 251.75M | 178.92M | 210.25M |
| Net receivables | 61.19M | 47.97M | 48.80M | 48.30M | 27.57M |
| Long term debt | 228.03M | 226.52M | 180.94M | 168.99M | 48.20M |
| Inventory | 0.00000M | - | - | - | - |
| Accounts payable | 6.64M | 4.42M | 4.69M | 5.33M | 3.62M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 0.03M | -0.64800M | -0.06700M | 0.06M | 0.07M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 0.05M | 0.04M | 0.04M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | -878.86000M | -725.65000M | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 6.94M | 3.73M | 4.50M | 3.61M | 0.81M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 310.62M | 324.49M | 323.70M | 247.94M | 38.12M |
| Capital lease obligations | 21.03M | 21.45M | 23.67M | 26.29M | 4.46M |
| Long term debt total | - | - | - | - | 48.20M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -39.02100M | -74.47000M | 29.54M | -205.33000M | 23.88M |
| Change to liabilities | -10.69900M | 12.84M | 8.24M | -0.00900M | 14.90M |
| Total cashflows from investing activities | -39.02100M | -139.67800M | -82.56500M | -209.60200M | 21.40M |
| Net borrowings | - | - | 143.70M | 25.35M | 9.95M |
| Total cash from financing activities | -2.61300M | 264.08M | 182.61M | 231.38M | 24.35M |
| Change to operating activities | -3.99600M | -8.32500M | -7.08100M | -4.84400M | -4.36700M |
| Net income | -137.40300M | -153.21000M | -115.01700M | -60.09600M | -61.98400M |
| Change in cash | -76.91500M | 101.27M | 73.92M | -10.39900M | 5.45M |
| Begin period cash flow | 193.23M | 91.95M | 18.03M | 28.43M | 22.98M |
| End period cash flow | 116.31M | 193.23M | 91.95M | 18.03M | 28.43M |
| Total cash from operating activities | -35.27000M | -23.12300M | -26.14800M | -32.18400M | -40.29600M |
| Issuance of capital stock | 0.00000M | 245.18M | 0.00000M | 206.72M | 33.99M |
| Depreciation | 48.30M | 37.53M | 18.73M | 9.21M | 7.41M |
| Other cashflows from investing activities | - | -54.75800M | -104.33300M | -205.26800M | 23.91M |
| Dividends paid | - | - | - | - | 0.00000M |
| Change to inventory | - | -8.32500M | -7.08100M | -3.65300M | 2.46M |
| Change to account receivables | 0.79M | 0.10M | -16.44800M | 0.13M | -3.62700M |
| Sale purchase of stock | -8.39300M | 270.37M | 40.54M | 0.00000M | -8.71200M |
| Other cashflows from financing activities | 1.81M | 18.90M | 239.65M | 58.55M | 33.06M |
| Change to netincome | 66.24M | 76.00M | 60.15M | 22.34M | 7.19M |
| Capital expenditures | 17.41M | 18.47M | 10.46M | 4.33M | 2.50M |
| Change receivables | - | 0.10M | -16.44800M | - | 0.00000M |
| Cash flows other operating | - | -4.44100M | 8.80M | - | 0.00000M |
| Exchange rate changes | - | - | - | - | 0.00000M |
| Cash and cash equivalents changes | - | 101.28M | 73.90M | - | 0.00000M |
| Change in working capital | -13.90700M | 4.62M | -3.82700M | -1.26600M | 9.75M |
| Stock based compensation | 72.10M | 65.14M | 37.96M | 17.84M | 4.20M |
| Other non cash items | 0.16M | 29.93M | 37.29M | 2.08M | 0.53M |
| Free cash flow | -52.68400M | -41.59000M | -36.61300M | -36.51800M | -42.79900M |
Sector: Healthcare Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst Inc |
0.06 0.80% | 6.96 | - | 19.01 | 1.21 | 0.97 | 0.97 | -4.2091 |
| GEHC GE HealthCare Technologies Inc. |
0.63 0.79% | 79.99 | 22.91 | 20.12 | 2.01 | 5.52 | 2.39 | 13.30 |
| VEEV Veeva Systems Inc Class A |
-4.88 2.24% | 212.55 | 54.61 | 33.22 | 12.83 | 6.73 | 11.14 | 58.84 |
| MTHRF M3 Inc |
- -% | 9.73 | 29.72 | 25.00 | 0.05 | 4.38 | 0.04 | 0.12 |
| MTHRY M3 Inc |
-0.04 0.92% | 4.29 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
10897 South River Front Parkway, South Jordan, UT, United States, 84095
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel D. Burton | CEO & Director | 1975 |
| Mr. Bryan Truman Hunt | Chief Financial Officer | 1987 |
| Mr. Paul Horstmeier | Chief Operating Officer | 1961 |
| Mr. Daniel H. Orenstein | Gen. Counsel & Sec. | 1970 |
| Mr. J. Patrick Nelli Jr. | Sr. Advisor | NA |
| Mr. Jason Alger | Chief Accounting Officer | 1984 |
| Mr. Dave Ross | Chief Technology Officer | NA |
| Mr. Jason Jones | Chief Analytics & Data Science Officer and GM of Data & Analytics Platform | NA |
| Mr. Adam Brown | Sr. VP of Investor Relations and Financial Planning & Analysis | NA |
| Mr. Kyle J. Salyers | Sr. VP of Corp. Devel. | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...